Study Stopped
The PI, Dr. Younger, left Henry Ford Health.
Effect of Epidural Analgesia During Labor on Force of Maternal Push
1 other identifier
interventional
N/A
1 country
1
Brief Summary
There are multiple factors that determine progress of normal vaginal delivery. Frequency, duration and strength of uterine contractions are important for progress throughout labor, and abdominal wall muscle contractions contribute to progress during the final stage. Epidural analgesia helps to alleviate the pain associated with uterine contractions, this however this comes at the expense of prolonging labor by reducing the strength of abdominal wall muscle contractions. The purpose of this prospective study is to quantify how much epidurals decrease the strength of abdominal wall contractions. Intraabdominal pressure will be used as surrogate to strength of abdominal wall contractions, and it will be measured via a foley catheter inserted into the urinary bladder as part of standard procedure for patients receiving labor epidurals. We will compare the change in intraabdominal pressure when patients perform forceful abdominal contractions (valsalva maneuvers) prior to and during epidural analgesia. This will lay the foundation for a future study in which we plan to compare the effects of different epidural analgesia types and concentrations on abdominal wall muscle contractions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2020
CompletedFirst Submitted
Initial submission to the registry
May 6, 2021
CompletedFirst Posted
Study publicly available on registry
May 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2022
CompletedSeptember 25, 2023
September 1, 2023
1.7 years
May 6, 2021
September 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The change in intraabdominal pressure (surrogate of maternal force)
The change in intraabdominal pressure will be measured prior to receiving epidural analgesia, and again at 1 and 2 hours following administration. The change observed before and after will be compared to quantify the decreased change following epidural administration.
2 hours following initial administration of labor epidural
Secondary Outcomes (3)
Mode of delivery
Up to 72 hours after initial administration of labor epidural
Duration of second stage of labor
Up to 72 hours after initial administration of labor epidural
Apgar scores
Up to 72 hours after initial administration of labor epidural
Study Arms (1)
Epidural Analgesia
EXPERIMENTALAll subjects will be given epidural analgesia to treat their labor pain. As part of standard protocol for all patients who receive a labor epidural, the epidural will then be tested using 3ml of 1.5% lidocaine and 1:200,000 epinephrine test solution, and the epidural catheter will then be loaded with 10ml of 0.125% bupivacaine solution. The epidural catheter will then be connected to a programmed intermittent epidural bolus pump which will administer 5ml of a 0.125% bupivacaine/2mcg fentanyl solution every 30minutes. The first dose will be given following 30minutes after the loading dose. 30 minutes after loading the loading dose and after the first pump dose has been given, we will assess the VAS pain scores and the level of the analgesic based on decreased sensation to ice.
Interventions
As part of standard protocol for all patients who receive a labor epidural, the epidural will then be tested using 3ml of 1.5% lidocaine and 1:200,000 epinephrine test solution, and the epidural catheter will then be loaded with 10ml of 0.125% bupivacaine solution. The epidural catheter will then be connected to a programmed intermittent epidural bolus pump which will administer 5ml of a 0.125% bupivacaine/2mcg fentanyl solution every 30minutes. The first dose will be given following 30minutes after the loading dose. 30 minutes after loading the loading dose and after the first pump dose has been given, we will assess the VAS pain scores and the level of the analgesic based on decreased sensation to ice.
Eligibility Criteria
You may qualify if:
- Adult (18 years and older)
- Pregnant women in their third trimester
- Able to read and speak English
- Capacity to consent to participate
- Receiving a labor epidural catheter during their labor and delivery at HFH-Main
You may not qualify if:
- Severe cardiac disease
- People who are unable/medically recommended not to perform valsalva maneuvers
- People who are not undergoing labor epidural analgesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Henry Ford Hospital
Detroit, Michigan, 48202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Staff Anesthesiologist
Study Record Dates
First Submitted
May 6, 2021
First Posted
May 17, 2021
Study Start
November 2, 2020
Primary Completion
July 2, 2022
Study Completion
July 2, 2022
Last Updated
September 25, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to share individual participant data with other researchers.